CSE1L通过与TRIP13的分子交叉调节胃癌的进展
Guanghui Zhang1, Rui Yang2, Baiyan Wang1
1Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
International journal of biological macromolecules
|November 19, 2025
概括
细胞亡易感性1-like (CSE1L) 蛋白质促进胃癌 (GC) 的生长和扩散. 抑制CSE1L显著减少瘤进展,揭示了GC治疗的潜在新治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因,由于无症状的早期发展,通常在晚期被诊断为癌症.
- 紧急需要早期诊断生物标志物和新的治疗策略,以有效管理GC.
- 细胞亡敏感性蛋白质CSE1L与各种癌症中的瘤扩散有关.
研究的目的:
- 研究CSE1L在胃癌瘤发生和转移中的作用.
- 探索针对CSE1L进行GC治疗的潜力.
- 阐明CSE1L在GC中的功能背后的分子机制,包括它与TRIP13的相互作用.
主要方法:
- 在GC组织中分析CSE1L表达.
- 在GC细胞系和体内模型中对CSE1L进行基因淘汰.
- 使用分子生物学技术研究CSE1L和TRIP13之间的相互作用.
- 评估ubiquitination和蛋白质的稳定性.
主要成果:
- 在GC组织中,CSE1L显著上调,并在体外和体内促进GC细胞的增殖和转移.
- 对CSE1L的遗传制显示出强大的抗瘤作用.
- 在GC组织中观察到CSE1L和TRIP13表达之间的正相关性.
- 通过抑制其无处不在,CSE1L稳定了TRIP13,而TRIP13反过来稳定了CSE1L,形成了一个调节循环.
结论:
- CSE1L-TRIP13轴在胃癌的进展中起着至关重要的作用.
- 准CSE1L-TRIP13相互作用为胃癌提供了一个有前途的治疗策略.
- CSE1L是早期诊断的潜在生物标志物,也是GC的治疗目标.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K


